apnea has been researched along with Patency of the Ductus Arteriosus in 35 studies
Apnea: A transient absence of spontaneous respiration.
Excerpt | Relevance | Reference |
---|---|---|
"Aminophylline was effective for the prevention of apnea and intubation for apnea associated with PGE1 in infants with ductal-dependent congenital heart disease." | 9.10 | Aminophylline for the prevention of apnea during prostaglandin E1 infusion. ( Charpie, JR; Crowley, DC; Kim, DW; Kulik, TJ; Lim, DS; Maher, KO, 2003) |
"Doxapram has been advocated as a treatment for persistent apnea of prematurity (AOP)." | 7.83 | Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity. ( Brouwer, E; Onland, W; Rijken, M; Te Pas, AB; Ten Hove, CH; van Kaam, AH; van Wassenaer-Leemhuis, AG; Vliegenthart, RJ, 2016) |
" All postoperative apneas were identified." | 7.74 | The frequency of apneas in premature infants after inguinal hernia repair: do they need overnight monitoring in the intensive care unit? ( Ansermino, M; Milner, R; Murphy, JJ; Swanson, T, 2008) |
"Periods of apnea or severe hypoventilation may occur during procedures which involve the airway or during thoracic operations." | 7.66 | Transcutaneous gas tension monitoring in the management of intraoperative apnea. ( Harley, DP; Hauser, CJ, 1983) |
" Infants in the restrictive-transfusion group were more likely to have intraparenchymal brain hemorrhage or periventricular leukomalacia, and they had more frequent episodes of apnea, including both mild and severe episodes." | 5.11 | Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. ( Bell, EF; Cress, GA; Johnson, KJ; Kromer, IJ; Mahoney, LT; Mock, DM; Seward, VJ; Strauss, RG; Widness, JA; Zimmerman, MB, 2005) |
"Aminophylline was effective for the prevention of apnea and intubation for apnea associated with PGE1 in infants with ductal-dependent congenital heart disease." | 5.10 | Aminophylline for the prevention of apnea during prostaglandin E1 infusion. ( Charpie, JR; Crowley, DC; Kim, DW; Kulik, TJ; Lim, DS; Maher, KO, 2003) |
"Caffeine use in preterm infants has endured several paradigms: from standard of care to possible neurotoxin to one of the few medications for which there is evidence of bronchopulmonary dysplasia (BPD) risk reduction." | 4.98 | Caffeine controversies. ( Carlo, WA; Gentle, SJ; Travers, CP, 2018) |
"Apnea of prematurity (AOP) is a common and pervasive problem in very low birth weight infants." | 4.98 | Caffeine: an evidence-based success story in VLBW pharmacotherapy. ( Dobson, NR; Hunt, CE, 2018) |
"The introduction of methylxanthines, especially caffeine, for the treatment of apnea of prematurity has been one of the most important and effective therapies in the neonatal intensive care unit (NICU) to date." | 4.88 | Evidence-based methylxanthine use in the NICU. ( Spitzer, AR, 2012) |
" These factors (immaturity, hyperoxia, hypoxia, blood transfusions, intraventricular hemorrhage, apnea, infection, hypercarbia, hypocarbia, patent ductus arteriosus, prostaglandin synthetase inhibitors, vitamin E deficiency, lactic acidosis, prenatal complications, genetic factors) may all be present in an infant." | 4.76 | A reexamination of the role of oxygen in retrolental fibroplasia. ( Dangman, B; Lucey, JF, 1984) |
" Side effects of apnea and fever are often dose dependent and occur within 48 h after initiation." | 4.31 | Standardizing Prostaglandin Initiation in Prenatally Diagnosed Ductal-Dependent Neonates; A Quality Initiative. ( Conaway, MR; Dean, PN; Elliott, MR; Haughey, BS; Swanson, JR; White, SC; Wiggin, JY, 2023) |
"Caffeine to prevent or treat apnea of prematurity in the newborn period is now standard of care for infants born very preterm." | 3.96 | Childhood respiratory outcomes after neonatal caffeine therapy. ( Cheong, JLY; Doyle, LW, 2020) |
"346), apnea (OR = 2." | 3.88 | Retinopathy of Prematurity Among Very Low-Birth-Weight Infants in China: Incidence and Perinatal Risk Factors. ( Mu, D; Qu, Y; Tong, Y; Wu, T; Xia, B; Zhang, L, 2018) |
"Doxapram has been advocated as a treatment for persistent apnea of prematurity (AOP)." | 3.83 | Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity. ( Brouwer, E; Onland, W; Rijken, M; Te Pas, AB; Ten Hove, CH; van Kaam, AH; van Wassenaer-Leemhuis, AG; Vliegenthart, RJ, 2016) |
"In very preterm neonates, early (prophylactic) caffeine use was associated with a reduction in the rates of death or bronchopulmonary dysplasia and patent ductus arteriosus." | 3.81 | Association of early caffeine administration and neonatal outcomes in very preterm neonates. ( Barrington, K; Lee, SK; Lodha, A; McMillan, DD; Seshia, M; Shah, PS; Yang, J, 2015) |
" All postoperative apneas were identified." | 3.74 | The frequency of apneas in premature infants after inguinal hernia repair: do they need overnight monitoring in the intensive care unit? ( Ansermino, M; Milner, R; Murphy, JJ; Swanson, T, 2008) |
"Periods of apnea or severe hypoventilation may occur during procedures which involve the airway or during thoracic operations." | 3.66 | Transcutaneous gas tension monitoring in the management of intraoperative apnea. ( Harley, DP; Hauser, CJ, 1983) |
" The most frequent complications are apnea with bradycardia and/or a significant left-to-right shunt through a patent ductus arteriosus." | 3.66 | The immature lung: radiographic appearance, course, and complications. ( Edwards, DK; Gluck, L; Jacob, J, 1980) |
"To characterize the dosing and safety of off-label caffeine citrate in a contemporary cohort of extremely premature infants." | 1.51 | Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants. ( Bendel-Stenzel, E; Chhabra, R; Harper, B; Ku, L; Laughon, M; Moya, F; Payne, EH; Puia-Dumitrescu, M; Smith, PB; Soriano, A; Wade, KC; Zhao, J, 2019) |
" Qualitative and quantitative differences in pharmacokinetics and pharmacodynamics of drugs should be considered before dosage regimens can be established." | 1.27 | [Peculiarities of drug therapy in childhood]. ( Kusenbach, G; Reinhardt, D, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (51.43) | 18.7374 |
1990's | 1 (2.86) | 18.2507 |
2000's | 5 (14.29) | 29.6817 |
2010's | 9 (25.71) | 24.3611 |
2020's | 2 (5.71) | 2.80 |
Authors | Studies |
---|---|
Haughey, BS | 1 |
Elliott, MR | 1 |
Wiggin, JY | 1 |
Conaway, MR | 1 |
White, SC | 1 |
Swanson, JR | 1 |
Dean, PN | 1 |
Cheong, JLY | 1 |
Doyle, LW | 1 |
Gentle, SJ | 1 |
Travers, CP | 1 |
Carlo, WA | 1 |
Wu, T | 1 |
Zhang, L | 1 |
Tong, Y | 1 |
Qu, Y | 1 |
Xia, B | 1 |
Mu, D | 1 |
Dobson, NR | 1 |
Hunt, CE | 1 |
Puia-Dumitrescu, M | 1 |
Smith, PB | 1 |
Zhao, J | 1 |
Soriano, A | 1 |
Payne, EH | 1 |
Harper, B | 1 |
Bendel-Stenzel, E | 1 |
Moya, F | 1 |
Chhabra, R | 1 |
Ku, L | 1 |
Laughon, M | 1 |
Wade, KC | 1 |
Lodha, A | 1 |
Seshia, M | 1 |
McMillan, DD | 1 |
Barrington, K | 1 |
Yang, J | 1 |
Lee, SK | 1 |
Shah, PS | 1 |
Ten Hove, CH | 1 |
Vliegenthart, RJ | 1 |
Te Pas, AB | 1 |
Brouwer, E | 1 |
Rijken, M | 1 |
van Wassenaer-Leemhuis, AG | 1 |
van Kaam, AH | 1 |
Onland, W | 1 |
Macintosh, JLB | 1 |
Huggins, LJ | 1 |
Eden, LM | 1 |
Merrill, KC | 1 |
Luthy, KEB | 1 |
Spitzer, AR | 2 |
Doheny, L | 1 |
Morey, JA | 1 |
Ringer, SA | 1 |
Lahav, A | 1 |
Lim, DS | 1 |
Kulik, TJ | 1 |
Kim, DW | 1 |
Charpie, JR | 1 |
Crowley, DC | 1 |
Maher, KO | 1 |
Bell, EF | 1 |
Strauss, RG | 1 |
Widness, JA | 1 |
Mahoney, LT | 1 |
Mock, DM | 1 |
Seward, VJ | 1 |
Cress, GA | 1 |
Johnson, KJ | 1 |
Kromer, IJ | 1 |
Zimmerman, MB | 1 |
Meier, SD | 1 |
Eble, BK | 1 |
Stapleton, GE | 1 |
Morales, DL | 1 |
Chang, AC | 1 |
Andropoulos, DB | 1 |
Hand, IL | 1 |
Noble, LM | 1 |
Murphy, JJ | 1 |
Swanson, T | 1 |
Ansermino, M | 1 |
Milner, R | 1 |
Lucey, JF | 2 |
Dangman, B | 1 |
Hauser, CJ | 1 |
Harley, DP | 1 |
Flynn, JT | 1 |
Edwards, DK | 1 |
Jacob, J | 1 |
Gluck, L | 1 |
Habel, A | 1 |
Jones, MD | 1 |
Murton, LJ | 1 |
Bartel, J | 1 |
Müller, WD | 1 |
Zach, M | 1 |
Stix, H | 1 |
Rosegger, H | 1 |
Beitzke, A | 1 |
Fariello, R | 1 |
Olley, PM | 1 |
Coceani, F | 1 |
Coran, AG | 1 |
Cabal, L | 1 |
Siassi, B | 1 |
Rosenkrantz, JG | 1 |
Roberton, NR | 1 |
Smith, MA | 1 |
Sevely, A | 1 |
Fries, F | 1 |
Regnier, C | 1 |
Manelfe, C | 1 |
Davis, JM | 1 |
Abbasi, S | 1 |
Johnson, L | 1 |
Reinhardt, D | 1 |
Kusenbach, G | 1 |
Ahlström, H | 1 |
Smith, PC | 1 |
Smith, NT | 1 |
Sahn, DJ | 1 |
Friedman, WF | 1 |
Murphy, DA | 1 |
Outerbridge, E | 1 |
Stern, L | 1 |
Karn, GM | 1 |
Jegier, W | 1 |
Rosales, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Early Use of Caffeine Citrate in Preterm Neonates Needing Respiratory Support.[NCT04001712] | Phase 3 | 54 participants (Actual) | Interventional | 2019-04-05 | Completed | ||
A Randomized, Placebo-controlled Trial of Early Caffeine in Preterm Neonates[NCT03086473] | Phase 4 | 24 participants (Actual) | Interventional | 2017-02-01 | Active, not recruiting | ||
Randomized Trial of Liberal Versus Restrictive Guidelines for Red Blood Cell Transfusion in Preterm Infants[NCT00369005] | 100 participants | Interventional | 1992-12-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for apnea and Patency of the Ductus Arteriosus
Article | Year |
---|---|
Caffeine controversies.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Drug Administration | 2018 |
Caffeine: an evidence-based success story in VLBW pharmacotherapy.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Ductus Arteriosus, Patent; Enterocolitis, Necrot | 2018 |
Evidence-based methylxanthine use in the NICU.
Topics: Apnea; Bronchopulmonary Dysplasia; Ductus Arteriosus, Patent; Evidence-Based Medicine; Humans; Infan | 2012 |
A reexamination of the role of oxygen in retrolental fibroplasia.
Topics: Anencephaly; Apnea; Carbon Dioxide; Cerebral Hemorrhage; Ductus Arteriosus, Patent; Exchange Transfu | 1984 |
Clinical uses of transcutaneous oxygen monitoring.
Topics: Apnea; Blood Pressure; Ductus Arteriosus, Patent; Electrodes; Enterocolitis, Pseudomembranous; Human | 1981 |
Mechanical ventilation in newborn infants with hyaline membrane disease;.
Topics: Acidosis; Apnea; Birth Weight; Bradycardia; Cerebral Hemorrhage; Ductus Arteriosus, Patent; Gestatio | 1977 |
[Drug therapy of patent ductus arteriosus in premature and newborn infants].
Topics: Apnea; Aspirin; Chloroquine; Digitalis Glycosides; Ductus Arteriosus, Patent; Humans; Indomethacin; | 1978 |
Difficulties in distinguishing cardiac from pulmonary disease in the neonate.
Topics: Apnea; Arteriovenous Malformations; Carbon Dioxide; Cardiovascular System; Cyanosis; Diagnosis, Diff | 1973 |
2 trials available for apnea and Patency of the Ductus Arteriosus
Article | Year |
---|---|
Aminophylline for the prevention of apnea during prostaglandin E1 infusion.
Topics: Alprostadil; Aminophylline; Apnea; Bradycardia; Bronchodilator Agents; Double-Blind Method; Ductus A | 2003 |
Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants.
Topics: Anemia; Apnea; Blood Donors; Brain Damage, Chronic; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; | 2005 |
25 other studies available for apnea and Patency of the Ductus Arteriosus
Article | Year |
---|---|
Standardizing Prostaglandin Initiation in Prenatally Diagnosed Ductal-Dependent Neonates; A Quality Initiative.
Topics: Alprostadil; Apnea; Cardiac Surgical Procedures; Ductus Arteriosus, Patent; Heart Defects, Congenita | 2023 |
Childhood respiratory outcomes after neonatal caffeine therapy.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Child; Citrates; Duc | 2020 |
Retinopathy of Prematurity Among Very Low-Birth-Weight Infants in China: Incidence and Perinatal Risk Factors.
Topics: Apnea; Birth Weight; Blood Transfusion; Bronchopulmonary Dysplasia; China; Ductus Arteriosus, Patent | 2018 |
Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Cerebral Hemorrhage; Citrates; Ductus Arteriosus, Paten | 2019 |
Association of early caffeine administration and neonatal outcomes in very preterm neonates.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Canada; Ductus Arteriosus, Patent; Gestational Age; Hum | 2015 |
Association of early caffeine administration and neonatal outcomes in very preterm neonates.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Canada; Ductus Arteriosus, Patent; Gestational Age; Hum | 2015 |
Association of early caffeine administration and neonatal outcomes in very preterm neonates.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Canada; Ductus Arteriosus, Patent; Gestational Age; Hum | 2015 |
Association of early caffeine administration and neonatal outcomes in very preterm neonates.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Canada; Ductus Arteriosus, Patent; Gestational Age; Hum | 2015 |
Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Central Nervous System Stimulants; Child Development; Doxapram; D | 2016 |
Immunization Status of NICU Graduates at a Tertiary Care Children's Hospital.
Topics: Adrenal Cortex Hormones; Age Factors; Apnea; Bradycardia; Bronchopulmonary Dysplasia; Continuous Pos | 2017 |
Reduced frequency of apnea and bradycardia episodes caused by exposure to biological maternal sounds.
Topics: Abruptio Placentae; Apgar Score; Apnea; Bradycardia; Cesarean Section; Continuous Positive Airway Pr | 2012 |
Mesenteric oxyhemoglobin desaturation improves with patent ductus arteriosus ligation.
Topics: Apnea; Cerebellum; Ductus Arteriosus, Patent; Echocardiography; Embolization, Therapeutic; Female; H | 2006 |
Caffeine for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Ductus Arteriosus, P | 2006 |
The frequency of apneas in premature infants after inguinal hernia repair: do they need overnight monitoring in the intensive care unit?
Topics: Apnea; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Comorbidity; Ductus Arteriosus, Patent; Fema | 2008 |
Transcutaneous gas tension monitoring in the management of intraoperative apnea.
Topics: Adult; Apnea; Blood Gas Analysis; Ductus Arteriosus, Patent; Humans; Infant, Newborn; Intraoperative | 1983 |
Acute proliferative retrolental fibroplasia: multivariate risk analysis.
Topics: Analysis of Variance; Anemia; Apnea; Birth Weight; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; | 1983 |
The immature lung: radiographic appearance, course, and complications.
Topics: Apnea; Body Weight; Bradycardia; Ductus Arteriosus, Patent; Enterocolitis, Pseudomembranous; Female; | 1980 |
Pathogenesis of neonatal apnoea.
Topics: Apnea; Ductus Arteriosus, Patent; Humans; Infant, Newborn; Infant, Newborn, Diseases; Lung Volume Me | 1977 |
[Indomethacin in IRDS with PDA phenomenon (author's transl)].
Topics: Apnea; Ductus Arteriosus, Patent; Humans; Indomethacin; Infant, Newborn; Respiratory Distress Syndro | 1979 |
Neurological and electroencephalographic changes in newborns treated with prostaglandins E1 and E2.
Topics: Apnea; Brain; Cyanosis; Ductus Arteriosus, Patent; Electroencephalography; Heart Defects, Congenital | 1977 |
Surgical closure of patent ductus arteriosus in the premature infant with respiratory distress.
Topics: Aortography; Apnea; Birth Weight; Blood Pressure; Ductus Arteriosus, Patent; Electrocardiography; Fe | 1975 |
Early neonatal hypocalcaemia.
Topics: Apnea; Asphyxia Neonatorum; Birth Weight; Calcium; Ductus Arteriosus, Patent; Erythroblastosis, Feta | 1975 |
Doppler ultrasound study of the anterior cerebral artery in neonates.
Topics: Apnea; Asphyxia Neonatorum; Blood Flow Velocity; Cerebral Arteries; Cerebral Hemorrhage; Cerebrovasc | 1991 |
Role of theophylline in pathogenesis of necrotizing enterocolitis.
Topics: Apgar Score; Apnea; Birth Weight; Ductus Arteriosus, Patent; Enterocolitis, Pseudomembranous; Gestat | 1986 |
[Peculiarities of drug therapy in childhood].
Topics: Apnea; Biological Availability; Biotransformation; Caffeine; Child; Child, Preschool; Dexamethasone; | 1986 |
Studies on pulmonary mechanics in infants.
Topics: Airway Resistance; Apnea; Asphyxia Neonatorum; Catheterization; Ductus Arteriosus, Patent; Heart Sep | 1974 |
Anaesthetic management of a very premature infant. Case report.
Topics: Acid-Base Equilibrium; Anesthesia, General; Apnea; Body Temperature; Ductus Arteriosus, Patent; Fema | 1972 |
Management of premature infants with patent ductus arteriosus.
Topics: Apnea; Digitalis; Diuretics; Ductus Arteriosus, Patent; Female; Heart Auscultation; Heart Defects, C | 1974 |